This Cooperative Agreement award, totaling $6,166,318, was provided by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award aims to strengthen the capacity of healthcare organizations, community-based organizations, and state/local health departments to implement high-impact HIV prevention initiatives and address health disparities. Key products and services to be delivered include:...
The Centers for Disease Control and Prevention (CDC) awarded a $4,989,475 Cooperative Agreement under the "Capacity Building Assistance (CBA) for High-Impact HIV Prevention" program (CFDA 93.834) to Public Health Foundation Enterprises, Inc. (doing business as Heluna Health), a non-profit organization. The award, with a performance period from August 2024 to March 2029, will support Heluna Health in providing technical assistance, training, and organizational development services to...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) provides $15,351,606 to Cicatelli Associates, Inc. (CAI) from August 2024 to March 2029. The funding supports CAI in delivering training, technical assistance, and capacity building services to health departments, community-based organizations, and other partners to strengthen the HIV prevention workforce's...
The Centers for Disease Control and Prevention (CDC) awarded a $4,950,311 Cooperative Agreement to Proceed Inc., doing business as the Puerto Rican Organization For Community Education & Economic Development, under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award supports two key activities: 1) Project REACH, a national CBA program to enhance the capabilities of community-based organizations (CBOs) and health departments in addressing HIV...
This $4,989,475 Cooperative Agreement was awarded by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The funding will support the Denver Prevention Training Center in delivering a broad spectrum of targeted HIV technical assistance (TA) services to CDC-funded programs and their local partners across the United States and its territories over a 5-year period from August 2024 to March 2029....
This $7,888,424 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) supports Healthhiv's National HIV eLearning Training Center. The project will deliver eLearning training and organizational/workforce development services to community-based organizations engaged in high-impact HIV prevention programs. Key activities include providing technical assistance, training,...
The Latino Commission on AIDS, Inc. was awarded a $4,989,475 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award, effective August 30, 2024 through March 31, 2029, aims to provide comprehensive capacity building assistance, including technical assistance, training, and organizational support, to community-based organizations, health departments, and healthcare...
The City & County of San Francisco's Public Health Department was awarded a $4,989,475 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The funding will support the department's GETSFCBA program, which will use an equity-focused and trauma-informed approach to provide tailored technical assistance, training, and organizational development to the...
The Regents of the University of California, San Francisco (UCSF) was awarded a $4,989,475 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award, effective August 30, 2024 through March 31, 2029, will provide technical assistance, training, and capacity building services to CDC-funded health departments and community-based organizations to strengthen their...
The University of Rochester, Infectious Diseases Division, Center for Community Practice (UR-CCP) was awarded a $4,989,476 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). This five-year award, running from August 2024 to March 2029, will allow UR-CCP to provide tailored technical assistance (TA) services to strengthen the capacity of the nation's HIV workforce. The...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $4,989,475 Cooperative Agreement to AIDS United under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award aims to implement scalable technical assistance (TA) strategies to bolster the capacity of CDC-funded health departments and community-based organizations to strengthen HIV syndemic systems and services.
AIDS United and its implementation partners will use a flexible, continuous consultation approach to provide tailored TA, encompassing mentoring, skills building, and resource development. Collaborating with health departments, community-based organizations, other CBA providers, and people living with and at high risk for HIV, the project will ensure accessibility and cultural relevance through services such as mentoring sessions, skills enhancement workshops, and peer-to-peer knowledge exchange. The award has an initial performance period from August 2024 to March 2029.